Protalix BioTherapeutics Files 8-K on Officer/Director Changes
Ticker: PLX · Form: 8-K · Filed: Apr 23, 2025 · CIK: 1006281
| Field | Detail |
|---|---|
| Company | Protalix Biotherapeutics, Inc. (PLX) |
| Form Type | 8-K |
| Filed Date | Apr 23, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-director-changes, filing
TL;DR
Protalix BioTherapeutics 8-K: Leadership changes and financial updates filed April 23rd.
AI Summary
Protalix BioTherapeutics, Inc. filed an 8-K on April 23, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. The filing also includes financial statements and exhibits, with the earliest event reported being April 21, 2025.
Why It Matters
This filing indicates potential shifts in the company's leadership and governance structure, which could impact strategic direction and operational oversight.
Risk Assessment
Risk Level: medium — Changes in directors or officers can signal internal shifts that may affect company strategy or stability.
Key Players & Entities
- Protalix BioTherapeutics, Inc. (company) — Registrant
- April 21, 2025 (date) — Earliest event reported
- April 23, 2025 (date) — Date of report
FAQ
What specific changes occurred regarding directors or officers?
The filing indicates events related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers' but does not detail the specific individuals or changes within this 8-K header.
When was the earliest event reported in this filing?
The earliest event reported was on April 21, 2025.
What is the primary business of Protalix BioTherapeutics, Inc.?
Protalix BioTherapeutics, Inc. is in the business of BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
In which state is Protalix BioTherapeutics, Inc. incorporated?
Protalix BioTherapeutics, Inc. is incorporated in Delaware.
What is the SEC file number for Protalix BioTherapeutics, Inc.?
The SEC file number for Protalix BioTherapeutics, Inc. is 001-33357.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 23, 2025 regarding Protalix BioTherapeutics, Inc. (PLX).